A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiency

TransCon growth hormone is a sustained-release human growth hormone prodrug under development in which unmodified growth hormone is transiently linked to a carrier molecule. It is intended as an alternative to daily growth hormone in the treatment of growth hormone deficiency. This was a multi-cente...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Endocr Connect
Hlavní autoři: Höybye, Charlotte, Pfeiffer, Andreas F H, Ferone, Diego, Christiansen, Jens Sandahl, Gilfoyle, David, Christoffersen, Eva Dam, Mortensen, Eva, Leff, Jonathan A, Beckert, Michael
Médium: Artigo
Jazyk:Inglês
Vydáno: Bioscientifica Ltd 2017
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5424766/
https://ncbi.nlm.nih.gov/pubmed/28196799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-17-0007
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky